coronavirus
$10 billion raised to fund development of #Coronavirus vaccine – #Oxfam comment
Commenting on the announcement by the European Commission that $10.4 billion had been raised to fund the research and development of vaccines, treatments and tests for the coronavirus, Anna Marriott, Health Policy Manager for Oxfam said: “Most people will be happy to see public funds invested in the development of vaccines for the coronavirus. But governments must be clear about how this money is spent, and what conditions they are attaching to ensure that any eventual vaccine is distributed according to need, and made available to every individual, in every nation, free of charge. Vaccines should be a public good – not the private property of the pharmaceutical industry.”
The Coronavirus Global Response pledging marathon was launched on 4 May 2020.
Share this article:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
-
Health4 days agoCounterfeit cigarettes drive illicit tobacco trade to highest level in a decade, new study claims
-
Libya4 days agoLibya’s fuel crisis offers lessons for energy security on both sides of the Mediterranean
-
Law4 days agoEU Cybersecurity Act could expose member states to costly investment treaty claims, legal opinion warns
-
European Commission4 days agoSpring semester package: Steering EU economies to increased competitiveness
